Corrigendum to“Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment”[Bioact Mater 24(2022)37–53]
摘要
The authors regret that two images in Fig.3A were originally misplaced by a careless mistake.The corrected versions of these images are provided below.These corrections do not alter any findings and conclusions reported in this article.No additional text corrections are needed in the article.The authors would like to apologise for any inconvenience caused.
-
1Qiushi Liang,Zhiliang Cheng,Ling Qin.Advanced nanoparticles in osteoarthritis treatment[J].Biomaterials Translational,2024,5(2):95-113.
-
2Yaping Peng,Xinqiao Lian,Yan Wang,Xin Li.Matrine, a potential drug for the treatment of rheumatoid arthritis[J].Rheumatology & Autoimmunity,2024,4(1):11-19.
-
3Chunchun Xue,Jia Tian,Zepeng Cui,Yang Liu,Dawei Sun,Mengting Xiong,Nanxing Yi,Kaiqiang Wang,Xiaofeng Li,Yongjun Wang,Hao Xu,Weian Zhang,Qianqian Liang.Reactive oxygen species(ROS)-mediated M1 macrophage-dependent nanomedicine remodels inflammatory microenvironment for osteoarthritis recession[J].Bioactive Materials,2024(3):545-561. 被引量:1
-
4GUO Yanding,LUO Kun,ZHANG Linlin,LU Wenting,SHANG Yanan,ZHONG Yumei,HU Danhui,YANG Xin,ZHOU Haiyan.Study on the anti-inflammatory mechanism of moxibustion in rheumatoid arthritis in rats based on phospholipaseA2 signaling inhibition by Annexin 1[J].Journal of Traditional Chinese Medicine,2024,44(4):753-761.